IHAM
BEAM icon

Integral Health Asset Management’s Beam Therapeutics BEAM Stock Holding History

Integral Health Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.15M Sell
300,000
-250,000
-45% -$6.94M 0.34% 70
2025
Q4 		$15.2M Buy
550,000
+150,000
+38% +$3.83M 0.76% 47
2025
Q3 		$9.71M Sell
400,000
-100,000
-20% -$1.99M 0.66% 54
2025
Q2 		$8.51M Buy
+500,000
New +$8.71M 0.78% 37

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Integral Health Asset Management's BEAM Position: Q1 2026 in Review

Integral Health Asset Management reduced its Beam Therapeutics (BEAM) stake by 45% in Q1 2026, selling an estimated $6.94M and leaving 300,000 shares worth $7.15M. The position accounts for 0.34% of the portfolio, ranked #70.

Integral Health Asset Management first reported a position in BEAM in Q2 2025 and has held it in 4 quarters since. The position peaked at $15.2M in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Integral Health Asset Management held 300,000 shares of Beam Therapeutics worth $7.15M as of Q1 2026.
  • Integral Health Asset Management sold 250,000 Beam Therapeutics shares in Q1 2026, an estimated $6.94M.
  • Beam Therapeutics made up 0.34% of Integral Health Asset Management's portfolio in Q1 2026, its #70 holding.
  • Integral Health Asset Management first reported a position in Beam Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Integral Health Asset Management's Beam Therapeutics position peaked at $15.2M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.